The acquisition of CBD Therapeutics by Pasha Brands brings excitement to the Canadian market. CBC Therapeutics was already a major player pre-legalization. It is Canada’s largest retailer of CBD in Canada, based in British Columbia, which sells directly to the consumer. They are also well known for their mission to educate the general public and consumers on CBD. They pride themselves on quality and are continuously developing new products to bring better and more effective products to their customers.
The CEO of CBD Therapeutics, James Whitehead, is optimistic about the future as he believes this acquisition will help further their mission of making CBD more accessible. The company is focused on building relationships and on growing their company to bring the best of products to more Canadians and to those who need it the most. Pasha Brands Ltd. is Canada’s largest craft cannabis brands organization and the partnership of top cannabis and CBD is sure to be a good one. The goal is to keep up with supply post-legalization and to continue to provide top-quality cannabis and CBD.
Since October 2018, CBD Therapeutics has been preparing for the legalized and regulated market. Along with their acquisition, Pasha Brands has taken the names, trademarks, and intellectual property of CBD Therapeutics. They are now looking to re-launch the brand in the Canadian regulated market. This will not only benefit CBD Therapeutics, but Pasha Brands will profit from CBD Therapeutics’ existing client-base as well as their brand awareness. The brand is well respected, and Pasha Brands is looking to honour and continue their work in the new legalized cannabis world.